@article{article, title = {{The importance of adjusting for treatment crossover bias in oncology clinical trials: An analysis of the EGF104900 trial in metastatic breast cancer (mBC).}}, publisher = {{American Society of Clinical Oncology (ASCO)}}, url = {{}}, year = {{2013}}, month = {{5}}, author = {{Paracha N and Davies A and Latimer N and Parker C and Mealing S and Scott D and Padhiar A and Schulpher M and Wang Q}}, doi = {{10.1200/jco.2013.31.15_suppl.636}}, volume = {{31}}, journal = {{Journal of Clinical Oncology}}, issue = {{15_suppl}}, pages = {{636-636}}, note = {{Accessed on 2025/04/10}}}